What is Immunic Inc?
, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. Its lead development program is IMU-838, which is in Phase 3 clinical and phase 2 clinical development for patients with relapsing and progressive multiple sclerosis; and moderate-to-severe ulcerative colitis. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 111.01M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.